205 related articles for article (PubMed ID: 11485578)
21. Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
Boon L; Ugarte-Berzal E; Martens E; Vandooren J; Rybakin V; Colau D; Gordon-Alonso M; van der Bruggen P; Stöcker W; Becker-Pauly C; Witters P; Morava E; Jaeken J; Proost P; Opdenakker G
FEBS J; 2019 Mar; 286(5):930-945. PubMed ID: 30422384
[TBL] [Abstract][Full Text] [Related]
22. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
23. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase.
Shimada T; Nakamura H; Ohuchi E; Fujii Y; Murakami Y; Sato H; Seiki M; Okada Y
Eur J Biochem; 1999 Jun; 262(3):907-14. PubMed ID: 10411655
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha.
Rawdanowicz TJ; Hampton AL; Nagase H; Woolley DE; Salamonsen LA
J Clin Endocrinol Metab; 1994 Aug; 79(2):530-6. PubMed ID: 8045973
[TBL] [Abstract][Full Text] [Related]
26. Non-human primate models; artificial menstrual cycles, endometrial matrix metalloproteinases and s.c. endometrial grafts.
Brenner RM; Rudolph L; Matrisian L; Slayden OD
Hum Reprod; 1996 Oct; 11 Suppl 2():150-64. PubMed ID: 8982757
[TBL] [Abstract][Full Text] [Related]
27. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
[TBL] [Abstract][Full Text] [Related]
28. Activation of human progelatinase A/promatrix metalloproteinase 2 by Escherichia coli-derived serine proteinase.
Takeda M; Imada K; Sato T; Ito A
Biochem Biophys Res Commun; 2000 Feb; 268(1):128-32. PubMed ID: 10652225
[TBL] [Abstract][Full Text] [Related]
29. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
30. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis.
Kinoh H; Sato H; Tsunezuka Y; Takino T; Kawashima A; Okada Y; Seiki M
J Cell Sci; 1996 May; 109 ( Pt 5)():953-9. PubMed ID: 8743942
[TBL] [Abstract][Full Text] [Related]
31. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation.
Stack MS; Itoh Y; Young TN; Nagase H
Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767
[TBL] [Abstract][Full Text] [Related]
32. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle.
Irwin JC; Kirk D; Gwatkin RB; Navre M; Cannon P; Giudice LC
J Clin Invest; 1996 Jan; 97(2):438-47. PubMed ID: 8567965
[TBL] [Abstract][Full Text] [Related]
33. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Wang FQ; So J; Reierstad S; Fishman DA
Int J Cancer; 2005 Mar; 114(1):19-31. PubMed ID: 15523695
[TBL] [Abstract][Full Text] [Related]
34. Activation of progelatinase B in synovial fluids of patients with rheumatoid arthritis, with reference to stromelysin-1 and tissue inhibitor of matrix metalloproteinase-1.
Watanabe Y; Yamaguchi R; IwakiEgawa S; Shimamori Y; Fujimoto Y; Matsuno H
Clin Exp Rheumatol; 1999; 17(4):401-6. PubMed ID: 10464548
[TBL] [Abstract][Full Text] [Related]
35. Production of matrix metalloproteinase 1 (interstitial collagenase) and matrix metalloproteinase 2 (gelatinase A: 72 kDa gelatinase) by ovine endometrial cells in vitro: different regulation and preferential expression by stromal fibroblasts.
Salamonsen LA; Nagase H; Suzuki R; Woolley DE
J Reprod Fertil; 1993 Jul; 98(2):583-9. PubMed ID: 8410828
[TBL] [Abstract][Full Text] [Related]
36. Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumor of bone.
Sasaguri Y; Komiya S; Sugama K; Suzuki K; Inoue A; Morimatsu M; Nagase H
Am J Pathol; 1992 Sep; 141(3):611-21. PubMed ID: 1519668
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of spontaneous rat osteosarcoma lung metastasis by 3S-[4-(N-hydroxyamino)-2R-isobutylsuccinyl]amino-1-methoxy-3,4-dihydroc arbostyril, a novel matrix metalloproteinase inhibitor.
Kido A; Tsutsumi M; Iki K; Motoyama M; Takahama M; Tsujiuchi T; Morishita T; Tatsumi K; Tamai S; Konishi Y
Jpn J Cancer Res; 1999 Mar; 90(3):333-41. PubMed ID: 10359049
[TBL] [Abstract][Full Text] [Related]
38. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
39. TIMP-2 is required for efficient activation of proMMP-2 in vivo.
Wang Z; Juttermann R; Soloway PD
J Biol Chem; 2000 Aug; 275(34):26411-5. PubMed ID: 10827175
[TBL] [Abstract][Full Text] [Related]
40. Expression of matrix metalloproteinase enzymes in endometrium of women with abnormal uterine bleeding.
Grzechocinska B; Dabrowski FA; Chlebus M; Gondek A; Czarzasta K; Michalowski L; Cudnoch-Jedrzejewska A; Wielgos M
Neuro Endocrinol Lett; 2018 Feb; 38(8):537-543. PubMed ID: 29504731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
